
Zinotinel Tablet 35 milligrams (Sodium Risedronate)
35mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Sodium risedronate is an ingredient used to improve bone density in the treatment of osteoporosis.
MFDS ingredient code M245359
Sodium risedronate is a medication belonging to the bisphosphonate class, primarily used for the treatment of osteoporosis. It is included in pharmaceuticals to suppress bone loss and increase bone density.
This ingredient reduces bone loss by inhibiting the activity of osteoclasts, which are cells that break down bone. As a result, bones become denser, and the risk of fractures decreases.
Approved uses differ by product. Check each product's information for its actual use.
Sodium risedronate has a relatively high absorption rate and prolonged action compared to other bisphosphonates. Additionally, it is characterized by relatively fewer gastrointestinal side effects when taken.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
7 total

35mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

35mg
Tablet · Prescription medication
Daehan Pharmaceutical Co., Ltd.

35mg
Tablet · Prescription medication
Genupharm Co., Ltd.

35mg
Tablet · Prescription medication
Medica Korea Co., Ltd.

35mg
Tablet · Prescription medication
IQURE Co., Ltd.

35mg
Tablet · Prescription medication
Gunil Biopharm Co., Ltd.

35mg
Tablet · Prescription medication
LightPharmTech Co., Ltd.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.